HOMEABOUT USBusiness Strategy

Business Strategy

Business Strategy
Business Strategy

BioPhoenix focuses on the critical links of the drug development value chain, advancing promising early-stage discoveries from academia and industry, and partnering to bring them through clinical development to successful market launch.

The LRCD Innovation Model maximizing leverage and minimizing risk
The LRCD Innovation Model maximizing leverage and minimizing risk

We adopt the LRCD (Leverage Research Co-Development) co-development strategy. This approach aims to connect and leverage diverse resources from industry, academia, research institutions, and medical sectors, along with Artificial Intelligence (AI) innovative technologies. By integrating internal and external R&D capabilities, we jointly develop promising new drugs, thereby sharing risks and development costs, accelerating new drug commercialization, and sharing successful outcomes.